The Israeli cannabis industry has been blocked for a while, mainly because the U.S. President Donald Trump asked the Prime Minister and Minister of Health of Israel to halt the export of cannabis flowers from Israel. However, one year after awaiting, cannabis export has received the final government approval. Israel can technically export cannabis, but only after meeting the domestic demand.
After years of delays, Israel’s cannabis industry can finally obtain a license to export its products to other countries. Israel has been at the forefront of medical cannabis research since the 1960s.
Laws in Israel have allowed researchers to innovate in a range of new cannabis products. Legislators quickly realized the economic potential of allowing their cannabis products to be sold abroad and in 2017 proposed to legalize the export of medical cannabis products.
Large-scale operations for Israel’s cannabis industry
Later in the same year, several Israeli cannabis growers started to operate on a large scale, hoping to sell their products internationally.
But at the beginning of 2018 Prime Minister Benjamin Netanyahu destroyed these hopes by blocking the export law for fear that cannabis from Israel would enter the black market. Regardless of this, legislators officially legalized medical cannabis exports in December 2019.
The adoption of this law renewed the interest of foreign investors interested in the Israeli cannabis industry, but the interest quickly weakened as the export prospects were again delayed.
At the request of President Trump, Prime Minister Netanyahu delayed the legalization of cannabis exports for almost a year. This month, these delays may come to an end as the government has given its final consent to the export of medical cannabis abroad.
Israel’s cannabis industry to begin exporting
Israeli cannabis companies can now export their products, but there is still a hook. Before international exports can be allowed, the local cannabis industry must first be able to satisfy the domestic demand for medical cannabis.
Unfortunately, there is a shortage of medical cannabis in Israel since one of the country’s largest growers, Tikun Olam, was temporarily closed due to concerns over the drying process.
“Many foreign investors decided to invest their funds and technological know-how abroad, establishing crops in places such as Malta and Uganda and investing or establishing hemp companies all over the world, from Poland to the U. S., Australia, and other countries,” explained Laura Kam, President of Kam Global Strategies.
All of this can now change with the lifting of the temporary export ban, but Israeli cannabis companies have yet to overcome a number of other regulatory obstacles before they can sell their goods abroad.
For example, in order to export goods to Europe, companies must comply with the Good Manufacturing Practice (Eu-GMP) standard and many Israeli cannabis companies do not yet meet these complex and demanding standards.
DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Hemp.im, its management, staff or its associates. Please review our disclaimer for more information.
This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.
First published in FaktyKonopne, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.
Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Hemp.im assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Hemp.im is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.